Abstract
The use of antibodies in transplantation has become a clinical reality. Antibodies have been used to both dampen the recipient’s immune response and to obscure the immunogenicity of the donor graft. Traditionally, antibodies have been administered to the transplant recipient to transiently inactivate the host’s T cells, the lymphocytes responsible for recognizing and attacking foreign proteins, cells, and tissues. Antibodies can also be used to eliminate any highly immunogenic passenger cells from a donor graft prior to transplantation, and antibodies can mask or conceal antigens present on donor cells that might trigger rejection.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Köhler, G. and Milstein, C. (1975) Continuous culture of fused cells secreting antibody of predefined specificity. Nature256, 495–497.
Medawar, P. B. (1957) The Uniqueness of the Individual, Basic Books, New York.
Russell, P. S. (1977) Antilymphocyte sera for immunosuppression, in Human Diagnosis and Therapy (Haber, E. and Krause, R., eds.), Raven, New York, pp. 303–355.
Anonymous (1985) A randomized clinical trial of OKT3 monoclonal antibody for acute rejection of cadaveric renal transplants. Ortho Multicenter Transplant Study Group. New Engl. J. Med.313, 337–342.
Thurlow, P. J., Lovering, E., d’Apice, A. J., and McKenzie, I. F. (1983) A monoclonal antipan-T cell antibody: in vitro and in vivo studies. Transplantation36, 293–298.
Takahashi, H., Okazaki, H., Terasaki, P. I., Iwaki, Y., Kinukawa, T., Taguchi, Y., Chia, D., Hardiwidjaja, S., Miura, K., and Ishizaki, M. (1983) Reversal of transplant rejection by monoclonal antiblast antibody. Lancet2, 1155–1158.
Kirkman, R. L., Araujo, J. L., Busch, G. J., Carpenter, C. B., Milford, E. L., Reinherz, E. L., Schlossman, S. F., Strom, T. B., and Tilney, N. L. (1983) Treatment of acute renal allograft rejection with monoclonal anti-T12 antibody. Transplantation36, 620–626.
Kneteman, N. M., Marchetti, P., Tordjman, K., Bier, D. M., Santiago, J. V., Swanson, C. J., Olack, B. J., and Scharp D. W. (1992) Effects of cyclosporine on insulin secretion and insulin sensitivity in dogs with intrasplenic islet autotransplants. Surgery111, 430–437.
Metrakos, P., Hornby, L., and Rosenberg, L. (1993) Cyclosporine and islet massimplications for islet transplantation. J. Surg. Res.54, 375–380.
Hering, B. J., Browatzki, C. C., Schultz, A., Bretzel, R. G., and Federlin, K. F. (1993) Clinical islet transplantation-registry report, accomplishments in the past and future research needs. Cell Transplant.2, 269–282.
Jacobs, B. B. (1974) Ovarian allograft survival. Prolongation after passage in vitro. Transplantation18, 454–457.
Lafferty, K., Cooley, M., Woolnough, J., and Walker, K. (1975) Thyroid allograft immunogenicity is reduced after a period of organ culture. Science188, 259–261.
Lacy, P. E., Davie, J. M., and Finke, E. H. (1979) Prolongation of islet allograft survival following in vitro culture (24°C) and a single injection of ALS. Science204, 312,313.
Naji, A., Silvers, W. K., and Barker, C. F. (1979) Effect of culture in 95% O2 on the survival of parathyroid allografts. Surg. Forum30, 109–111.
Parr, E. L., Bowen, K. M., and Lafferty, K. J. (1980) Cellular changes in cultured mouse thyroid glands and islets of Langerhans. Transplantation30, 135–141.
Opelz, G. and Terasaki, P. I. (1974) Lymphocyte antigenicity loss with retention of responsiveness. Science184, 464–466.
Parr, E. L. (1979) The absence of H-2 antigens from mouse pancreatic p-cells demonstrated by immunoferritin labeling. J. Exp. Med.150, 1–9.
Faustman, D., Hauptfeld, V., Davie, J., Lacy, P., and Shreffler, D. (1980) Murine pancreatic β cells express H-2K and H-2D but not Ia antigens. J. Exp. Med.151, 1563–1569.
Baekkeskov, S., Kanatsuna, T., Klareskog, L., Nielsen, D. A., Peterson, P. A., Rubenstein, A. H., Steiner, D. F., and Lernmark, A. (1981) Expression of major histocompatibility antigens on pancreatic islet cells. Proc. Natl. Acad. Sci. USA78, 6456–6460.
Faustman, D., Hauptfeld, V., Lacy, P., and Davie, J. (1981) Prolongation of murine islet allograft survival by pretreatment of islets with antibody directed to Ia determinants. Proc. Natl. Acad. Sci. USA78, 5156–5159.
Lechler, R. I. and Batchelor, J. R. (1982) Restoration of immunogenecity to passenger cell-depleted kidney allografts by the addition of donor strain dendritic cells. J. Exp. Med.155, 31–41.
Hart, D. N. and Fabre, J. W. (1981) Demonstration and characterization of Ia-positive dendritic cells in the interstitial connective tissue of rat heart and other tissues, but not brain. J. Exp. Med.154, 347–361.
Faustman, D., Steinman, R., Gebel, H., Hauptfeld, V., Davie, J., and Lacy, P. (1984) Prevention of rejection of murine islet allografts by pre-treatment with anti-dendritic cell antibody. Proc. Natl. Acad. Sci. USA81, 3864–3868.
Sone, Y., Sakagami, K., and Orita, K. (1987) Effect of ex vivo perfusion with anti-IA monoclonal antibodies on rat cardiac allograft survival. Transplant. Proc.19, 599–604.
Lloyd, M., Buckingham, M., Stuart, F., and Thistlethwaite, J. R. (1989) Does depletion of donor dendritic cells an allograft lead to prolongation of graft survival in transplantation? Transplant. Proc.21, 482–483.
Otsubo, O., Sakai, A., Watanabe, T., and Inoi, T. (1983) Effect of anti-mouse Ia monoclonal antibody on canine renal allograft survival. Transplant. Proc.15, 797–799.
Brewer, Y., Palmer, A., Taube, D., Welsh, K., Bewick, M., Bindon, C., Hale, G., Waldmann, H., Dische, F., Parsons, V., and Snowden, S. (1989) Effect of graft perfusion with two CD45 monoclonal antibodies on incidence of kidney allograft rejection. Lancet2, 935–937.
Spits, H., van Schooten, W., Keizer, H., van Seventer, G., van de Rijn, M., Terhorst, C., and de Vries, J. E. (1986) Alloantigen recognition is preceded by nonspecific adhesion of cytotoxic T cells and target cells. Science232, 403–405.
Faustman, D. and Coe, C. (1991) Prevention of xenograft rejection by masking donor HLA class I antigens. Science252, 1700–1702.
Wu, J., Menapace, L., Barisoni, D., and Armato, U. (1992) An anti-beta-2-microglobulin monoclonal antibody prevents the reactive proliferation of lym-phocytes elicited by allo-human epidermal cells. J. Immunol. Res.4, 21–25.
Isobe, M., Yagita, H., Okumura, K., and Ihara, A. (1992) Specific acceptance of cardiac allograft after treatment with antibodies to ICAM-1 and LFA-1. Science255, 1125–1127.
Koller, B. H. and Smithies, O. (1989) Inactivating the beta-2 microglobulin locus in mouse embryonic stem cells by homologous recombination. Proc. Natl. Acad. Sci. USA86, 8932–8935.
Zijlstra, M., Bix, M., Simister, N. E., Loring, J. M., Raulet, D. H., and Jaenisch, R. (1990) Beta 2-microglobulin-deficient mice lack CD4-8+cytolytic T cells. Nature344, 742–746.
Markmann, J. F., Bassiri, H., Desai, N. M., Odorico, J. S., Kim, J. I., Koller, B. H., Smithies, O., and Barker, C. F. (1992) Indefinite survival of MHC class I-deficient murine pancreatic islet allografts. Transplantation54, 1085–1089.
Coffman, T., Geier, S., Ibrahim, S., Griffiths, R., Spurney, R., Smithies, O., Koller, B., and Sanfilippo, F. (1993) Improved renal function in mouse kidney allografts lacking MHC class I antigens. J. Immunol.151, 425–435.
Li, X. and Faustman, D. (1993) Use of donor 32-microglobulin-deficient transgenic mouse liver cells for isografts, allografts, and xenografts. Transplantation55, 940–946.
Zijlstra, M., Auchincloss, H., Loring, J. M., Chase, C. M., Russell, P. S., and Jaenisch, R. (1992) Skin graft rejection by beta 2-microglobulin-deficient mice. J. Exp. Med.175, 885–893.
Markmann, J. F., Jacobson, J. D., Kiumura, H., Choti, M. A., Hickey, W. F., Fox, I. J., Silvers, W. K., Barker, C. F., and Naji, A. (1989) Modulation of the major histocompatibility complex antigen and the immunogenicity of islet allografts. Transplantation48, 478–486.
Barker, C. F., Markmann, J. F., Posselt, A. M., and Naji, A. (1991) Studies of privileged sites and islet transplantation. Transplant. Proc.23, 2138–2142.
Doherty, P. C., Knowles, B. B., and Wettstein, P. J. (1984) Immunological surveillance of tumors in the context of major histocompatibility complex restriction of T-cell function. Adv. Cancer Res.42, 1–65.
Hui, K., Grosveld, F., and Festenstein, H. (1984) Rejection of transplantable AKR leukaemia cells following MHC DNA-mediated cell transformation. Nature311, 750–752.
Rees, R. C., Buckle, A. M., Gelsthorpe, K., James, V., Potter, C. W., Rogers, K., and Jacob, G. (1988) Loss of polymorphic A and B locus HLA antigens in colon carcinoma. Br. J. Cancer57, 374–377.
Karre, K., Ljunggren, H. G., Piontek, G., and Kiessling, R. (1986) Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defense strategy. Nature319, 675–678.
Smith, M. E., Marsh, S. G., Bodmer, J. G., Glesthorpe, K., and Bodmer, W. F. (1989) Loss of HLA-A,B,C allele products and lymphocyte function-associated antigen 3 in colorectal neoplasia. Proc. Natl. Acad. Sci. USA86, 5557–5561.
Manson, L. A. (1991) Does antibody-dependent epitope masking permit progressive tumour growth in the face of cell-mediated cytotoxicity? Immunol. Today12, 352–355.
Osorio, R. W., Ascher, N. L., Jaenisch, R., Freise, C. E., Roberts, J. P., and Stock, P. G. (1993) Major histocompatibility complex class I deficiency prolongs islet allograft survival. Diabetes42, 1520–1527.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Humana Press Inc.
About this protocol
Cite this protocol
Faustman, D.L. (2000). Antibodies for Transplantation. In: George, A.J.T., Urch, C.E. (eds) Diagnostic and Therapeutic Antibodies. Methods in Molecular Medicine, vol 40. Humana, Totowa, NJ. https://doi.org/10.1385/1-59259-076-4:141
Download citation
DOI: https://doi.org/10.1385/1-59259-076-4:141
Publisher Name: Humana, Totowa, NJ
Print ISBN: 978-0-89603-798-4
Online ISBN: 978-1-59259-076-6
eBook Packages: Springer Protocols